<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28977201</article-id><article-id pub-id-type="pmc">5613726</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Relationship between High Red Cell Distribution Width and Systemic
Inflammatory Response Syndrome after Extracorporeal Circulation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Seth</surname><given-names>Harsh Sateesh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Mishra</surname><given-names>Prashant</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Khandekar</surname><given-names>Jayant V.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Raut</surname><given-names>Chaitanya</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mohapatra</surname><given-names>Chandan Kumar Ray</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ammannaya</surname><given-names>Ganesh Kumar K.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Saini</surname><given-names>Jaskaran Singh</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Vaibhav</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">
<label>1</label> Department of Cardiovascular and Thoracic Surgery Lokmanya
Tilak Municipal Medical College and General Hospital</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Harsh Sateesh Seth, Department of
Cardiovascular and Thoracic Surgery, Lokmanya Tilak Municipal Medical College and
General Hospital, Sion West, Mumbai, Maharashtra, India - Zip code: 400022.
Email: <email>seth.harsh@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2017</year></pub-date><volume>32</volume><issue>4</issue><fpage>288</fpage><lpage>294</lpage><history><date date-type="received"><day>02</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Cardiac surgical operations involving extracorporeal circulation may develop
severe inflammatory response. This severe inflammatory response syndrome
(SIRS) is usually associated with poor outcome with no predictive marker.
Red cell distribution width (RDW) is a routine hematological marker with a
role in inflammation. We aim to determine the relationship between RDW and
SIRS through our study.</p></sec><sec><title>Methods</title><p>A total of 1250 patients who underwent cardiac surgery with extracorporeal
circulation were retrospectively analyzed out of which 26 fell into the SIRS
criteria and 26 consecutive control patients were taken. RDW, preoperative
clinical data, operative time and postoperative data were compared between
SIRS and control groups.</p></sec><sec><title>Results</title><p>The demographic profile of the patients was similar. RDW was significantly
higher in the SIRS <italic>versus</italic> control group (15.5&#x000b1;2.0
<italic>vs.</italic> 13.03&#x000b1;1.90), respectively with
<italic>P</italic> value &#x0003c;0.0001. There was significant mortality in
the SIRS group, 20 (76.92%) as compared to 2 (7.6%) in control group with a
<italic>P</italic> value of &#x0003c;0.005. Multiple logistic regression
analysis revealed that there was significant association with high RDW and
development of SIRS after extracorporeal circulation (OR for RDW levels
exceeding 13.5%; 95% CI 1.0-1.2; <italic>P</italic>&#x0003c;0.05).</p></sec><sec><title>Conclusion</title><p>Increased RDW was significantly associated with increased risk of SIRS after
extracorporeal circulation. Thus, RDW can act as a useful tool to predict
SIRS in patients undergoing cardiac surgery with extracorporeal circulation.
Hence, more aggressive measures can be taken in patients with high RDW to
prevent postoperative morbidity and mortality.</p></sec></abstract><kwd-group><kwd>Erythrocyte Indices</kwd><kwd>Extracorporeal Circulation</kwd><kwd>Systemic Inflammatory Response Syndrome</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="38%" span="1"/><col width="4%" span="1"/><col width="10%" span="1"/><col width="38%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Activated clotting
time</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IL-6</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Interleukin-6</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute myocardial
infarction</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MCHC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mean cell hemoglobin
concentration</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MCV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mean corpuscular
volume</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Complete blood
count</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MOD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Multi Organ
Dysfunction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PaCO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Partial arterial carbon
dioxide pressure</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Extracorporeal
circulation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Red blood cell</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ET</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Endothelin</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RDW</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Red cell distribution
width</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ESR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Erythrocyte
sedimentation rate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Receiver operator
curve</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EuroSCORE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European system for
cardiac operative risk evaluation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HCT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hematocrit</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SIRS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Severe inflammatory
response syndrome</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">hs-CRP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= High-sensitive
C-reactive protein</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TNF-alpha</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Tumor necrosis
factor-alpha</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;= Intensive care
unit</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">WBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= White blood cell&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Cardiac surgery using cardiopulmonary bypass (CPB) provokes a systemic inflammatory
response. This is mainly triggered by contact activation of blood by artificial
surfaces of the extracorporeal circuit. Although often remaining subclinical and
resolving promptly at the end of CPB, in its most extreme form this inflammatory
response may be associated with the development of the systemic inflammatory
response syndrome (SIRS) that can often lead to multi organ dysfunction (MOD) and
death<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>Red cell distribution width (RDW) is a quantitative measure of anisocytosis, the
variability in size of the circulating erythrocytes. It is routinely measured by
automated haematology analysers and is reported as a component of the complete blood
count (CBC)<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>RDW is a recently described novel biomarker that has been shown to be predictive of
adverse outcomes in multiple cardiovascular disease settings, including stable
coronary artery disease, chronic heart failure and acute myocardial infarction
(AMI)<sup>[<xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r5" ref-type="bibr">5</xref>]</sup>. Although the plausible pathobiological mechanisms
explaining the relationship of RDW with adverse cardiovascular outcomes are yet to
be elucidated, both inflammation and oxidative stress are believed to play a
role<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>The molecular basis of the above mentioned association has been mainly attributed to
the ability of RDW's capability to reliably reflect an increase in the levels of
circulating cytokines, such as Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha
(TNF-alpha) and hepcidin<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>SIRS is a dreaded complication of any surgery. It is known to have a poor prognosis
and in the current scenario there are no useful laboratory and clinical parameters
to predict it. There has not been much work done elucidating the possible
association between high RDW and development of SIRS after extracorporeal
circulation (ECC).</p></sec><sec sec-type="methods"><title>METHODS</title><p>After approval of the study by ethics committee of our institution (IEC/67/16), we
retrospectively evaluated 1250 patients who underwent elective cardiac surgery with
ECC from August 2012 to August 2016. Two groups were formed (SIRS and control
groups), according to the following criteria.</p><sec><title>SIRS Group</title><p>According to this criterion, we identified 26 patients with SIRS, which presented
with two or more of the following features:</p><p><list list-type="bullet"><list-item><p>Temperature &#x02265;38&#x000ba;C or &#x02264;36&#x000ba;C; Heart rate &#x0003e;90
beats/min.</p></list-item><list-item><p>Respiratory rate &#x0003e;20 breaths/min or partial arterial carbon
dioxide pressure (PaCO<sub>2</sub>) &#x0003c;32 mmHg.</p></list-item><list-item><p>White blood cell (WBC) count &#x02265;12,000/&#x000b5;l or &#x02264;
4,000/&#x000b5;l<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p></list-item></list></p><p>Exclusion criteria: Mechanical ventilation more than 48 hours before surgery,
preoperative infection, death during surgical intervention or in the first 48
hours after surgery, proved postoperative infection within the first 5 days,
record with incomplete data.</p></sec><sec><title>Control Group</title><p>Twenty-six consecutive patients with similar demographic parameters who underwent
cardiac surgery with ECC were included in the study and who met the inclusion
criteria (elective operation, no preoperative infection, no coagulopathy,
ejection fraction &#x0003e;35%). These patients were operated in the similar
timeframe as that of the corresponding SIRS patient. Patients who developed SIRS
were excluded from the control group.</p></sec><sec><title>Data Collection</title><p>Demographic parameters were recorded as the patients were included in the study:
age, gender, weight, left ventricular ejection fraction, European system for
cardiac operative risk evaluation (EuroSCORE), hematological and biochemical
parameters. Perioperative data were taken as: type of surgery, cross-clamp time,
ECC duration and oxygenator type. Postoperative collected data were also taken
into consideration and recorded as: need for inotropic support, postoperative
complications such as SIRS, acute kidney injury (increased serum creatininemia
&#x02265;1.5 or urine output &#x0003c;0.6 ml/kg/h during six consecutive
hours)<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> and
mortality. Clinical signs such as heart rate, body temperature and respiration
rate were also recorded hourly in the intensive care unit (ICU). Serial arterial
blood gas analysis was done in the ICU.</p></sec><sec><title>Hematologic and Biochemical Measurements</title><p>The complete blood count (CBC) and biochemistry panel of our patients were
measured routinely after 12 hours from fasting at the time of admission.
Baseline RDW values were measured with the use of the Sysmex XT-2000i Automated
Hematology Analyzer (Roche Diagnostics, Mannheim, Germany) in our hospital's
laboratory and were reported as a coefficient of variation (percentage) of red
blood cell (RBC) volume. The normal reference range for RDW in our laboratory is
between 11.6% and 14.8%.</p></sec><sec><title>Operative details</title><p>The same anesthesiology and surgical team operated all the patients. Standard
median sternotomy incision with aortic cannulation, single or bicaval
cannulation with membrane oxygenator (Terumo CAPIOX) with application of single
cross-clamp and administration antegrade root cold blood cardioplegia with mild
to moderate systemic hypothermia (28-32&#x000ba;C) in all patients. All patients were
heparinized with 300 units/kg before establishment of ECC. Activated clotting
time (ACT) was checked at 15-minute intervals until the target ACT of 450-600
seconds was achieved which is when CPB was initiated. All patients who underwent
coronary artery bypass grafting (CABG) had at least one arterial graft (left
internal mammary artery) as well as venous grafts (great saphenous vein).
Proximal anastomosis was done on a beating heart using a side-biting clamp.
Valve replacements were performed using pledgeted sutures in horizontal mattress
fashion. All patients received antibiotic prophylaxis at the time of induction
with cefazolin sodium 30 mg/kg at induction and repeated every four hours during
surgery.</p></sec><sec><title>Statistical Analysis</title><p>Statistical analysis was performed using MedCalc statistical software version
10.3.0.0 for Windows. Data are presented as the mean &#x000b1; standard deviation
(SD) for continuous variables and percentage for categorical variables.
Student's t-test was used to compare continuous variables and the chi-square
test was used for categorical variables. A <italic>P</italic>-value &#x0003c;0.05
indicates statistical significance. Multiple logistic regression analysis was
used to evaluate the independent predictors of SIRS occurrence.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>After the retrospective analysis of patients as per the inclusion and exclusion
criteria, 26 patients came under SIRS group and 26 consecutive patients were
assigned in the control group.</p><p>The distribution of inclusion criteria was as follows: temperature (&#x0003e;38&#x000ba;C) in 5
(19.2%) patients, heart rate &#x0003e;90/min in 18 (69.2%) patients, respiratory rate
abnormalities in 22 (84.6%) patients and WBC criteria in 10 (38.4%) patients.</p><p>Baseline clinical and demographic parameters are summarized in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline clinical and demographic parameters.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">SIRS group (n=26)</th><th align="center" rowspan="1" colspan="1">Control group (n=26)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">61.66&#x000b1;9.2</td><td align="center" rowspan="1" colspan="1">56.8&#x000b1;19.2</td><td align="center" rowspan="1" colspan="1">0.250</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (F/M)</td><td align="center" rowspan="1" colspan="1">10 -16</td><td align="center" rowspan="1" colspan="1">12 -14</td><td align="center" rowspan="1" colspan="1">0.574</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0.085</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypercholesterolemia</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0.447</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction</td><td align="center" rowspan="1" colspan="1">48.5&#x000b1;9.5</td><td align="center" rowspan="1" colspan="1">50.5&#x000b1;9.5</td><td align="center" rowspan="1" colspan="1">0.566</td></tr><tr><td align="left" rowspan="1" colspan="1">Active smoker</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">0.777</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">0.759</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic obstructive lung disease</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0.358</td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE</td><td align="center" rowspan="1" colspan="1">4.52&#x000b1;2.38</td><td align="center" rowspan="1" colspan="1">4.10&#x000b1;2.20</td><td align="center" rowspan="1" colspan="1">0.503</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>SIRS=systemic inflammatory response syndrome; F=female; M=male</p></fn></table-wrap-foot></table-wrap><p>Both groups were homogeneous in terms of age, gender, smoking habits, presence of
diabetes mellitus and predisposition to allergy, presence of hypercholesterolemia,
preoperative ejection fraction and the presence of chronic obstructive lung disease,
hypertension and EuroSCORE. Operative data of the patients are summarized in <xref ref-type="table" rid="t2">Table 2</xref>. We found significant differences
between the two groups regarding total operation time, number of units of blood
transfused and need for inotropic support. Significant postoperative mortality
occurred among the SIRS group patients of whom 20 (76.92%) were lost, whereas this
turned out to be 2 (7.6%) in the control group (<italic>P</italic>&#x0003c;0.001). The
hematological parameters are presented in <xref ref-type="table" rid="t3">Table
3</xref>. WBC, RBC, hematocrit (HCT), mean corpuscular volume (MCV), mean cell
hemoglobin concentration (MCHC), platelet, and creatinine levels were similar in
both groups. Of the total 1250 patients, 33 of them had high preoperative RDW. Out
of the 26 patients who developed SIRS, 22 of them had high preoperative RDW values.
However, RDW was significantly higher in the SIRS group <italic>versus</italic> the
control group (15.5&#x000b1;2.0 <italic>vs.</italic> 13.03&#x000b1;1.90),
respectively, <italic>P</italic>&#x0003c;0.0001. In addition, preoperative blood glucose
levels were also found to be significantly higher in the SIRS group
<italic>versus</italic> the control group (116&#x000b1;22 <italic>vs.</italic>
90&#x000b1;14), respectively, <italic>P</italic>&#x0003c;0.0001 (<xref ref-type="fig" rid="f1">Figure 1</xref>). Multiple logistic regression analyses showed an
association between high RDW levels and SIRS development (OR for RDW levels
exceeding 13.5%; 95% CI 1-1.2; <italic>P</italic>&#x0003c;0.05) (<xref ref-type="fig" rid="f2">Figure 2</xref>). The receiver operator curve (ROC) analysis suggested
that the optimum cut-off level of RDW for SIRS was 12.9% (sensitivity: 93.74%;
specificity: 76%; area under the curve: 0.851, <italic>P</italic>&#x0003c;0.05).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Operative data of both groups.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">SIRS group (n=26)</th><th align="center" rowspan="1" colspan="1">Control group (n=26)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Combined surgery (coronary/valve)</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0.531</td></tr><tr><td align="left" rowspan="1" colspan="1">Isolated valve</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">0.559</td></tr><tr><td align="left" rowspan="1" colspan="1">Isolated CABG</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Operation time (min)</td><td align="center" rowspan="1" colspan="1">182.7&#x000b1;44.2</td><td align="center" rowspan="1" colspan="1">132.6&#x000b1;38.8</td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="TFN3">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiopulmonary bypass time (min)</td><td align="center" rowspan="1" colspan="1">136&#x000b1;40.3</td><td align="center" rowspan="1" colspan="1">121&#x000b1;30.5</td><td align="center" rowspan="1" colspan="1">0.136</td></tr><tr><td align="left" rowspan="1" colspan="1">Cross-clamp time (min)</td><td align="center" rowspan="1" colspan="1">98.3&#x000b1;40.6</td><td align="center" rowspan="1" colspan="1">88.2&#x000b1;20.8</td><td align="center" rowspan="1" colspan="1">0.264</td></tr><tr><td align="left" rowspan="1" colspan="1">Need for inotropic support</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0.0002<xref ref-type="table-fn" rid="TFN3">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Number of blood transfusion (unit)</td><td align="center" rowspan="1" colspan="1">2&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">1.2&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">0.006<xref ref-type="table-fn" rid="TFN3">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intra-aortic balloon pump</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.297</td></tr><tr><td align="left" rowspan="1" colspan="1">Major complications</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>CABG=coronary artery bypass grafting; SIRS=systemic inflammatory response
syndrome</p></fn><fn id="TFN3"><label>*</label><p>Statistically significant</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Laboratory parameters.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">SIRS group (n=26)</th><th align="center" rowspan="1" colspan="1">Control group (n=26)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">WBC (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>) (NR
4-11)</td><td align="center" rowspan="1" colspan="1">9.42&#x000b1;3.75</td><td align="center" rowspan="1" colspan="1">8.34&#x000b1;3.55</td><td align="center" rowspan="1" colspan="1">0.291</td></tr><tr><td align="left" rowspan="1" colspan="1">RBC (&#x000d7;10<sup>6</sup>/mm<sup>3</sup>) (NR
4.2-5.7)</td><td align="center" rowspan="1" colspan="1">4.64&#x000b1;0.754</td><td align="center" rowspan="1" colspan="1">4.44&#x000b1;0.88</td><td align="center" rowspan="1" colspan="1">0.382</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>) (NR
150-400)</td><td align="center" rowspan="1" colspan="1">245&#x000b1;85.66</td><td align="center" rowspan="1" colspan="1">242&#x000b1;83.33</td><td align="center" rowspan="1" colspan="1">0.898</td></tr><tr><td align="left" rowspan="1" colspan="1">HCT (%) (NR 35-50)</td><td align="center" rowspan="1" colspan="1">38&#x000b1;5.8</td><td align="center" rowspan="1" colspan="1">37&#x000b1;5.4</td><td align="center" rowspan="1" colspan="1">0.522</td></tr><tr><td align="left" rowspan="1" colspan="1">MCV (fL) (NR 77-96)</td><td align="center" rowspan="1" colspan="1">84.44&#x000b1;6.07</td><td align="center" rowspan="1" colspan="1">86.55&#x000b1;7.06</td><td align="center" rowspan="1" colspan="1">0.253</td></tr><tr><td align="left" rowspan="1" colspan="1">MCHC g Hb/dl (32-36)</td><td align="center" rowspan="1" colspan="1">33&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">33&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">RDW (%) (NR 11.6-14.8)</td><td align="center" rowspan="1" colspan="1">15.5&#x000b1;2</td><td align="center" rowspan="1" colspan="1">13.03&#x000b1;1.90</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN5">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PO blood creatinine (mg/dl) (NR 0.5-1.5)</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.23</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.32</td><td align="center" rowspan="1" colspan="1">0.897</td></tr><tr><td align="left" rowspan="1" colspan="1">PO fasting blood glucose (mg/dl) (NR 76-110)</td><td align="center" rowspan="1" colspan="1">116&#x000b1;22</td><td align="center" rowspan="1" colspan="1">90&#x000b1;14</td><td align="center" rowspan="1" colspan="1">0.0001<xref ref-type="table-fn" rid="TFN5">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>Hb=hemoglobin; HCT=hematocrit; NR=normal range; RBC=red blood cell;
RDW=red cell distribution width; SIRS=systemic inflammatory response
syndrome; WBC=white blood cell; MCV=mean corpuscular volume; MCHC=mean
cell hemoglobin concentration; PO=postoperative.</p></fn><fn id="TFN5"><label>*</label><p>Statistically significant</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Graphical representation of preoperative glucose levels and operation
time between SIRS and control groups.</p></caption><graphic xlink:href="rbccv-32-04-0288-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Comparison of levels of red cell distribution width in SIRS and control
groups.</p></caption><graphic xlink:href="rbccv-32-04-0288-g02"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>This study shows us the importance of preoperative RDW as a predictive marker for
development of SIRS after ECC. RDW is a routine parameter available in complete
blood count.</p><p>This syndrome occurs in about 0.5-1.7% of patients after ECC and can be associated
with multiple organ failure which has a mortality of 40-60%, which can also be
higher<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Although
perioperative SIRS occurs in about 2% of all ECC procedures, the mortality is high
and comparable to that of severe sepsis<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>In our study, the incidence of SIRS was 2.08% of the patients with a mortality of
76.92%. The patients who expired in the SIRS group ultimately had multiorgan
failure. ECC is crucial part of many cardiac surgical operations. Multiple factors
associated with the use of CPB contribute toward the generation of perioperative
SIRS. These include the generation of shear forces from roller pumps driving blood
through the bypass circuit, hypothermia as blood is passed through the
extracorporeal circuit, and contact activation of plasma protein systems as
circulating blood is exposed to artificial surfaces in the bypass circuit. The
generation and release of endogenous inflammatory mediators leading to the
development of SIRS follow this<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.
The main underlying molecular mechanisms of such inflammation are activation of the
complement system, increasing production of cytokines, oxygen radicals, release of
endothelin (ET) and the expression of adhesion molecules on leukocytes and the
endothelium<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>.</p><p>In 2007, Felker et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> firstly
discovered that increasing RDW is an independent predictor for the prognosis of
heart failure patients, and researchers gradually discovered that RDW is closely
associated with the prognosis of cardiovascular diseases. Recent studies showed that
increasing RDW is not only a predictor for poor prognosis of heart failure. But it
also exhibits a predictive value towards the prognosis of stable coronary artery
disease patients who have underwent percutaneous coronary intervention therapy.</p><p>Red cell differentiation is also related to oxidative stress and to the release of
cytokines in response to inflammation induced by cardiac surgery<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Oxidative stress directly
damages erythrocytes and leads to shortened erythrocyte survival, resulting in
elevated RDW<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Lippi et
al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> showed a
correlation between RDW and indices of inflammation, such as elevated erythrocyte
sedimentation rate (ESR) and high-sensitive C-reactive protein (hs-CRP), identifying
a strong and graded increase in both ESR and hs-CRP across various RDW values. In a
study by Semba et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> it was
found that antioxidant status might influence RDW and play a role in the
relationship between increased RDW and worsened clinical prognosis. These cytokines
attenuate the activity of erythropoietin and cause the production of ineffective red
blood cells, leading to elevated RDW<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.</p><p>Perlstein et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> showed that
RDW strongly predicted all-cause and cardiovascular mortality. Lapp&#x000e9; et
al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> demonstrated that
RDW was associated with mortality in patients with stable coronary disease and in
normal coronary subjects. In addition, RDW is also an independent prognostic factor
for patients with peripheral arterial disease. In one study, a 10% increased risk of
mortality was observed with a 1% increase in RDW<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. In our study, patients with a high RDW value
over 13.5% had increased incidence of SIRS and the relation became even stronger if
the RDW value was more than 15%. In a study by Kumar et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>, patients with higher RDW had a
longer ICU stay (155.6&#x000b1;71.3 <italic>vs.</italic> 122.4&#x000b1;61.3 hours,
<italic>P</italic>=0.02). It was consisent with our study showing significant
morbidity in the SIRS group as compared to control group in terms of length of ICU
stay (158.2&#x000b1;72.3 hours <italic>vs.</italic> 100.2&#x000b1;44.2 hours,
<italic>P</italic>&#x0003c;0.001). Cemin et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> also found that RDW was a significant predictor of AMI,
exhibiting an area under the curve of 0.61 (95% CI, 0.54-0.68).</p><p>The sensitivity and specificity of RDW at the 13.7% cut-off value were 0.75 and 0.52,
respectively. In our study, ROC analysis suggested that the optimum cut-off level of
RDW for SIRS was 12.9% (sensitivity: 93.74%; specificity: 76%; area under the curve:
0.851, <italic>P</italic>&#x0003c;0.05), and the mean operation period was significantly
longer in the SIRS group than the control group.</p><p>In accordance with total operation time, ECC time was found longer in the SIRS group,
but it did not reach to statistical significance. Kirklin et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> emphasized that an increase in
ECC time from 60 to 120 minutes would also increase postoperative morbidity in all
age groups. There was a difference in the operating times, but the clamp time and
ECC times were similar in the two groups. There was not one particular cause for the
same but some of them are as follows: there was increased time taken to harvest the
left internal mammary artery in few patients of CABG. In some patients, there were
cardiotomy-bleeding points, which needed reinforcement sutures. In some there was
bleeding from the aortic line, which needed reinforcement sutures. In some patients
after coming off CPB, there was an oozy field, which needed to be addressed hence
took time before chest closure. The fact that clamp time and ECC times were similar
in our study suggests that the ECC time could not be considered as a confounding
factor. The operating time, which was higher in the SIRS group, was the time either
before onset or after termination of ECC.</p><p>Preoperative high blood glucose levels were also found to be significant in the SIRS
group in comparison with the control group. This condition can hypothetically be
explained with cardiac and pulmonary stress induced by catecholamine release, which
results in increased preoperative glucose levels<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>. In our study, there was a significant
correlation between number of units of blood transfused and development of SIRS.
These results suggest that high preoperative RDW can be used as an effective
predictive marker for SIRS in patients undergoing cardiac surgery with ECC. As
postulated, patients with high RDW have dysregulated erythropoiesis. These patients
may also have qualitative defects in their platelets, which may lead to increase
bleeding after ECC. This may be the reason that our patients with high RDW required
more transfusion. However, our study was not designed to establish objective
evidence of qualitative platelet dysfunction and to determine the possible causes of
SIRS, but we can only speculate on the possible causes (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Proposed hypothesis for correlation between high red cell distribution
width and SIRS.</p></caption><graphic xlink:href="rbccv-32-04-0288-g03"/></fig>
</p><p>The reason for high RDW is that under pulmonary or cardiovascular stress such as
hypoxia or low cardiac output, there is increased cytokine level, which attenuates
the activity of erythropoietin. This results in production of ineffective red blood
cells leading to an elevated RDW<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p><p>This study is retrospective and has its own limitations. The sample size is small as
the occurrence of SIRS is infrequent. This study does not take into account
congenital heart conditions. This is a single centre study for SIRS patients hence
they are a potential hindrance to its external validity. We also realize that there
were confounding factors like increased blood transfusion and increased operative
time in a few patients of the SIRS group. Nevertheless, high RDW had a significant
association in the development of SIRS after ECC in our study. Therefore, we also
recommend that a similar study with a higher sample size, prospective design and
randomized control should be done to validate these findings even further. This was
not possible in our setup.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In conclusion, the main finding to be noted is that there is a significant
association between elevated RDW and development of SIRS after ECC. This finding can
provide us with valuable information for predicting SIRS in patients undergoing
open-heart surgery without any additional costs, as RDW is a part of routine
complete blood count. This valuable piece of information can also be made to use
such that we find various alternatives to achieve the best result for our
patient:</p><list list-type="simple"><list-item><p>(1) avoiding CPB altogether (off pump surgery);</p></list-item><list-item><p>(2) removing activated neutrophils (leukodepletion filters);</p></list-item><list-item><p>(3) using hemofiltration in appropriate patients;</p></list-item><list-item><p>(4) we as clinicians should be watchful in patients with elevated RDW and
take appropriate aggressive measures.</p></list-item></list><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HSS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">PM</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis; final approval of the
version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JVK</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">CR</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">CKRM</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the analysis; final
approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">GKKA</td><td align="left" rowspan="1" colspan="1">Interpretation of data for the work; final approval of
the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JSS</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">VS</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Lokmanya Tilak Municipal Medical College and
General Hospital, Mumbai, India</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>JR</given-names></name><name><surname>Taylor</surname><given-names>KM</given-names></name></person-group><article-title>The systemic inflammatory response syndrome and cardiopulmonary
bypass</article-title><source>Int J Surg</source><year>2005</year><volume>3</volume><issue>2</issue><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">17462274</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kimmenade</surname><given-names>RR</given-names></name><name><surname>Mohammed</surname><given-names>AA</given-names></name><name><surname>Uthamalingam</surname><given-names>S</given-names></name><name><surname>van der Meer</surname><given-names>P</given-names></name><name><surname>Felker</surname><given-names>GM</given-names></name><name><surname>Januzzi</surname><given-names>JL Jr</given-names></name></person-group><article-title>Red blood cell distribution width and 1-year mortality in acute
heart failure</article-title><source>Eur J Heart Fail</source><year>2010</year><volume>12</volume><issue>2</issue><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">20026456</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozkalemkas</surname><given-names>F</given-names></name><name><surname>Ali</surname><given-names>R</given-names></name><name><surname>Ozkocaman</surname><given-names>V</given-names></name><name><surname>Ozcelik</surname><given-names>T</given-names></name><name><surname>Ozan</surname><given-names>U</given-names></name><name><surname>Ozturk</surname><given-names>H</given-names></name><etal/></person-group><article-title>The bone marrow aspirate and biopsy in the diagnosis of
unsuspected nonhematologic malignancy: a clinical study of 19
cases</article-title><source>BMC Cancer</source><year>2005</year><volume>5</volume><fpage>144</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">16262899</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabbah</surname><given-names>S</given-names></name><name><surname>Hammerman</surname><given-names>H</given-names></name><name><surname>Markiewicz</surname><given-names>W</given-names></name><name><surname>Aronson</surname><given-names>D</given-names></name></person-group><article-title>Relation between red cell distribution width and clinical
outcomes after acute myocardial infarction</article-title><source>Am J Cardiol</source><year>2010</year><volume>105</volume><issue>3</issue><fpage>312</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">20102941</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>KV</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Ershler</surname><given-names>WB</given-names></name><name><surname>Longo</surname><given-names>DL</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name></person-group><article-title>Red blood cell distribution width and the risk of death in
middle-aged and older adults</article-title><source>Arch Intern Med</source><year>2009</year><volume>169</volume><issue>5</issue><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">19273783</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonelli</surname><given-names>M</given-names></name><name><surname>Sacks</surname><given-names>F</given-names></name><name><surname>Arnold</surname><given-names>M</given-names></name><name><surname>Moye</surname><given-names>L</given-names></name><name><surname>Davis</surname><given-names>B</given-names></name><name><surname>Pfeffer</surname><given-names>M</given-names></name><collab>Cholesterol and Recurrent Events (CARE) Trial Investigators</collab></person-group><article-title>Relation between red blood cell distribution width and
cardiovascular event rate in people with coronary disease</article-title><source>Circulation</source><year>2008</year><volume>117</volume><issue>2</issue><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">18172029</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalo-Calvo</surname><given-names>D</given-names></name><name><surname>Lux&#x000e1;n-Delgado</surname><given-names>B</given-names></name><name><surname>Rodr&#x000ed;guez- Gonz&#x000e1;lez</surname><given-names>S</given-names></name><name><surname>Garc&#x000ed;a-Macia</surname><given-names>M</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>FM</given-names></name><name><surname>Solano</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Interleukin 6, soluble tumor necrosis factor receptor I and red
blood cell distribution width as biological markers of functional dependence
in an elderly population: a translational approach</article-title><source>Cytokine</source><year>2012</year><volume>58</volume><issue>2</issue><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">22309694</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Boylan</surname><given-names>JF</given-names></name><name><surname>Cheng</surname><given-names>DC</given-names></name></person-group><article-title>The systemic inflammatory response to cardiac surgery:
implications for the anesthesiologist</article-title><source>Anesthesiology</source><year>2002</year><volume>97</volume><issue>1</issue><fpage>215</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">12131125</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nashef</surname><given-names>SA</given-names></name><name><surname>Roques</surname><given-names>F</given-names></name><name><surname>Hammill</surname><given-names>BG</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><name><surname>Michel</surname><given-names>P</given-names></name><name><surname>Grover</surname><given-names>FL</given-names></name><etal/><collab>EuroSCORE Project Group</collab></person-group><article-title>Validation of European System for Cardiac Operative Risk
Evaluation (EuroSCORE) in North American cardiac surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2002</year><volume>22</volume><issue>1</issue><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">12103381</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Ronco</surname><given-names>C</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Mehta</surname><given-names>RL</given-names></name><name><surname>Palevsky</surname><given-names>P</given-names></name><collab>Acute Dialysis Quality Initiative workgroup</collab></person-group><article-title>Acute renal failure: definition, outcome measures, animal models,
fluid therapy and information technology needs: the Second International
Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
Group</article-title><source>Crit Care</source><year>2004</year><volume>8</volume><issue>4</issue><fpage>R204</fpage><lpage>R212</lpage><pub-id pub-id-type="pmid">15312219</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asimakopoulos</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>PL</given-names></name><name><surname>Ratnatunga</surname><given-names>CP</given-names></name><name><surname>Taylor</surname><given-names>KM</given-names></name></person-group><article-title>Lung injury and acute respiratory distress syndrome after
cardiopulmonary bypass</article-title><source>Ann Thorac Surg</source><year>1999</year><volume>68</volume><issue>3</issue><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="pmid">10510030</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>C</given-names></name><name><surname>Brunkhorst</surname><given-names>FM</given-names></name><name><surname>Bone</surname><given-names>HG</given-names></name><name><surname>Brunkhorst</surname><given-names>R</given-names></name><name><surname>Gerlach</surname><given-names>H</given-names></name><name><surname>Grond</surname><given-names>S</given-names></name><etal/></person-group><article-title>Epidemiology of sepsis in Germany: results from a national
prospective multicenter study</article-title><source>Intensive Care Med</source><year>2007</year><volume>33</volume><issue>4</issue><fpage>606</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">17323051</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sessler</surname><given-names>CN</given-names></name><name><surname>Shepherd</surname><given-names>W</given-names></name></person-group><article-title>New concepts in sepsis</article-title><source>Curr Opin Crit Care</source><year>2002</year><volume>8</volume><issue>5</issue><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">12357117</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felker</surname><given-names>GM</given-names></name><name><surname>Allen</surname><given-names>LA</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Shaw</surname><given-names>LK</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><etal/><collab>CHARM Investigators</collab></person-group><article-title>Red cell distribution width as a novel prognostic marker in heart
failure: data from the CHARM Program and the Duke Databank</article-title><source>J Am Coll Cardiol</source><year>2007</year><volume>50</volume><issue>1</issue><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17601544</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>JS</given-names></name><name><surname>Lopez</surname><given-names>MF</given-names></name><name><surname>Fleming</surname><given-names>MD</given-names></name><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>FM</given-names></name><name><surname>Welsh</surname><given-names>ML</given-names></name><etal/></person-group><article-title>SOD2-deficiency anemia: protein oxidation and altered protein
expression reveal targets of damage, stress response, and antioxidant
responsiveness</article-title><source>Blood</source><year>2004</year><volume>104</volume><issue>8</issue><fpage>2565</fpage><lpage>2573</lpage><pub-id pub-id-type="pmid">15205258</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippi</surname><given-names>G</given-names></name><name><surname>Targher</surname><given-names>G</given-names></name><name><surname>Montagnana</surname><given-names>M</given-names></name><name><surname>Salvagno</surname><given-names>GL</given-names></name><name><surname>Zoppini</surname><given-names>G</given-names></name><name><surname>Guidi</surname><given-names>GC</given-names></name></person-group><article-title>Relation between red blood cell distribution width and
inflammatory biomarkers in a large cohort of unselected
outpatients</article-title><source>Arch Pathol Lab Med</source><year>2009</year><volume>133</volume><issue>4</issue><fpage>628</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">19391664</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semba</surname><given-names>RD</given-names></name><name><surname>Patel</surname><given-names>KV</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Roy</surname><given-names>CN</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Serum antioxidants and inflammation predict red cell distribution
width in older women: the Women's Health and Aging Study I</article-title><source>Clin Nutr</source><year>2010</year><volume>29</volume><issue>5</issue><fpage>600</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">20334961</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name><name><surname>Woodman</surname><given-names>RC</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Lauretani</surname><given-names>F</given-names></name><name><surname>Corsi</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Proinflammatory state and circulating erythropoietin in persons
with and without anemia</article-title><source>Am J Med</source><year>2005</year><volume>118</volume><issue>11</issue><fpage>1288</fpage><lpage>1288</lpage></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlstein</surname><given-names>TS</given-names></name><name><surname>Weuve</surname><given-names>J</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Beckman</surname><given-names>JA</given-names></name></person-group><article-title>Red blood cell distribution width and mortality risk in a
community-based prospective cohort</article-title><source>Arch Intern Med</source><year>2009</year><volume>169</volume><issue>6</issue><fpage>588</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">19307522</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapp&#x000e9;</surname><given-names>JM</given-names></name><name><surname>Horne</surname><given-names>BD</given-names></name><name><surname>Shah</surname><given-names>SH</given-names></name><name><surname>May</surname><given-names>HT</given-names></name><name><surname>Muhlestein</surname><given-names>JB</given-names></name><name><surname>Lapp&#x000e9;</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Red cell distribution width, C-reactive protein, the complete
blood count, and mortality in patients with coronary disease and a normal
comparison population</article-title><source>Clin Chim Acta</source><year>2011</year><volume>412</volume><fpage>23</fpage><lpage>24</lpage><fpage>2094</fpage><lpage>2099</lpage></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Kullo</surname><given-names>IJ</given-names></name></person-group><article-title>Usefulness of red cell distribution width to predict mortality in
patients with peripheral artery disease</article-title><source>Am J Cardiol</source><year>2011</year><volume>107</volume><issue>8</issue><fpage>1241</fpage><lpage>1245</lpage><pub-id pub-id-type="pmid">21296321</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Sudhakar</surname><given-names>A</given-names></name><name><surname>Mohan</surname><given-names>M</given-names></name><name><surname>Balachandran</surname><given-names>R</given-names></name><name><surname>Raj</surname><given-names>B</given-names></name><name><surname>Sumangala</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Elevated red cell distribution width is associated with delayed
postoperative recovery after correction of Tetralogy of
Fallot</article-title><source>Ann Pediatr Cardiol</source><year>2013</year><volume>6</volume><issue>2</issue><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">24688227</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cemin</surname><given-names>R</given-names></name><name><surname>Donazzan</surname><given-names>L</given-names></name><name><surname>Lippi</surname><given-names>G</given-names></name><name><surname>Clari</surname><given-names>F</given-names></name><name><surname>Daves</surname><given-names>M</given-names></name></person-group><article-title>Blood cells characteristics as determinants of acute myocardial
infarction</article-title><source>Clin Chem Lab Med</source><year>2011</year><volume>49</volume><issue>7</issue><fpage>1231</fpage><lpage>1236</lpage><pub-id pub-id-type="pmid">21534844</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirklin</surname><given-names>JK</given-names></name><name><surname>Westaby</surname><given-names>S</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Kirklin</surname><given-names>JW</given-names></name><name><surname>Chenoweth</surname><given-names>DE</given-names></name><name><surname>Pacifico</surname><given-names>AD</given-names></name></person-group><article-title>Complement and the damaging effects of cardiopulmonary
bypass</article-title><source>J Thorac Cardiovasc Surg</source><year>1983</year><volume>86</volume><issue>6</issue><fpage>845</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">6606084</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidt</surname><given-names>T</given-names></name><name><surname>Sager</surname><given-names>HB</given-names></name><name><surname>Courties</surname><given-names>G</given-names></name><name><surname>Dutta</surname><given-names>P</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name><name><surname>Zaltsman</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chronic variable stress activates hematopoietic stem
cells</article-title><source>Nat Med</source><year>2014</year><volume>20</volume><issue>7</issue><fpage>754</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">24952646</pub-id></element-citation></ref></ref-list></back></article>